A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine whether a single IV dose of PF-04360365 is safe and
well tolerated in Adults with Mild to Moderate Alzheimer's disease.